Profile of Ding-Shinn Chen
| Autor: | Philip Downey |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Hepatitis
Hepatitis B virus medicine.medical_specialty Multidisciplinary business.industry Public health Taiwan History 20th Century Hepatitis B medicine.disease Chronic liver disease medicine.disease_cause Cancer Vaccines History 21st Century Virology Hepatitis B infection Liver disease medicine Humans Profile Hepatitis B Vaccines Public Health Liver cancer business |
| Zdroj: | Proceedings of the National Academy of Sciences |
| ISSN: | 1091-6490 0027-8424 |
| DOI: | 10.1073/pnas.0704698104 |
| Popis: | Worldwide, 350 million people are infected with the hepatitis B virus, one of five viruses that cause hepatitis that, in turn, increase the risk of chronic liver disease and liver cancer. Hepatitis B infection is especially prevalent in Southeast Asia and sub-Saharan Africa. Indeed, some of Chen's earliest work showed that hepatitis B infection in his homeland of Taiwan was far higher than in the West. Based on those findings, Chen worked to create a public health program in Taiwan that, for the past 23 years, has vaccinated nearly all of the newborns there against hepatitis B. The program already has reduced some forms of liver disease and, over the next several decades, should reduce it further or even eliminate it. Chen and his colleagues also have studied the molecular nuts and bolts of how hepatitis causes liver diseases. In his Inaugural Article (1), they report on a mechanism that may explain why hepatitis B causes liver cancer in males more than five times as often as females. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|